All In Biotech

Drug Trial Radar · NCT04333472

Piclidenoson for Treatment of COVID-19

Piclidenoson for Treatment of COVID-19 - A Randomized, Double-Blind, Placebo-Controlled Trial

Last checked: Nov 20, 2026Latest source record: Apr 22, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

6

Actual

Start

Jan 6, 2021

Primary completion

Mar 6, 2022

Study completion Apr 21, 2022

Sponsor

Lead sponsor
Can-Fite BioPharmaIndustry
Sponsor type
Industry
Collaborators
Rabin Medical Center
First posted
Apr 3, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Patients with documented moderate COVID-19 infection will be randomized 1:1 to receive piclidenoson 2 mg Q12H orally with standard supportive care (SSC - intervention arm) or placebo orally with SSC (control arm) for up to 28 days.

Conditions

  • COVID-19
  • Coronavirus Infection

Interventions

  • PiclidenosonDrug

    Piclidenoson 2 mg orally every 12 hours for up to 28 days

  • PlaceboDrug

    Placebo orally every 12 hours for up to 28 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of subjects alive and free of respiratory failureTime frame: 29 days
  2. Proportion of subjects discharged home aliveTime frame: 29 days
  3. Treatment-emergent adverse events (AEs)Time frame: 29 days

Locations

6 sites in 3 countries. Site status is shown where the registry gives one.

  • II Multiprofile Hospital for Active Treatment - Sofia EAD

    Sofia, Bulgaria

  • IV Multiprofile Hospital for Active Treatment - Sofia EAD

    Sofia, Bulgaria

  • Hadassah Medical Center

    Jerusalem, Israel

  • Shaare Zedek Medical Center

    Jerusalem, Israel

  • Clinical Hospital for Infectious Diseases "St. Parascheva" Iasi

    Iași, Romania

  • "Sfantul Ioan cel Nou" County Emergency Hospital Suceava

    Suceava, Romania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.